Search Results for 'Nrti Backbone'

Nrti Backbone published presentations and documents on DocSlides.

Comparison of INSTI vs PI
Comparison of INSTI vs PI
by conchita-marotz
FLAMINGO. GS-236-0103. ACTG . A5257. WAVES. . De...
Comparison of NNRTI vs PI/r
Comparison of NNRTI vs PI/r
by alexa-scheidler
EFV vs LPV/r vs EFV + LPV/r . A5142. Mexican. . ...
Management of NRTI Resistance
Management of NRTI Resistance
by giovanna-bartolotta
David Spach, MD. Principal . Investigator, NW AET...
Switch a ATV/r   3TC Estudio ATLAS-M
Switch a ATV/r 3TC Estudio ATLAS-M
by pamella-moone
ATV/r 300/100 mg QD 3TC 300 mg QD. N = 133. N =...
HIV Treatment 101 C. Ryan Tomlin, Pharm.D., BCPS, AAHIVP
HIV Treatment 101 C. Ryan Tomlin, Pharm.D., BCPS, AAHIVP
by Powerpixel
Clinical Pharmacist – HIV Medicine. Outline. Wha...
DTG vs LPV/r (DAWNING): Efficacy
DTG vs LPV/r (DAWNING): Efficacy
by winnie
by Baseline NRTI Resistance . and Second-Line NRTI...
DTG-Based Regimens Are Active in INI-Naive Patients With a
DTG-Based Regimens Are Active in INI-Naive Patients With a
by trish-goza
Jim Demarest. ,. 1. Mark Underwood,. 2. Marty S...
NRTI-sparing
NRTI-sparing
by min-jolicoeur
SPARTAN. PROGRESS. NEAT001/ANRS 14. 3 . MODERN. R...
Crafting an ART Regimen for Initiation or Salvage:
Crafting an ART Regimen for Initiation or Salvage:
by mitsue-stanley
Are NRTI’s Necessary?. Brian R. Wood, MD. Assis...
HIV Drug Resistance in Well-Resourced Settings
HIV Drug Resistance in Well-Resourced Settings
by faustina-dinatale
Vincent Marconi, . MD. Outline. Transmitted Drug ...
Switch to LPV/
Switch to LPV/
by lindy-dunigan
r. + 3TC. OLE . Study. LPV/. r. bid + 3TC or FT...
Comparison of NRTI combinations
Comparison of NRTI combinations
by tawny-fly
ZDV/3TC . vs. TDF + FTC. Study 934. ABC/3TC . vs...
NRTI-sparing
NRTI-sparing
by liane-varnes
SPARTAN. PROGRESS. RADAR. NEAT001/ANRS 14. 3. A40...
Roy M. Gulick, MD, MPH Gladys and Roland Harriman Professor of Medicine
Roy M. Gulick, MD, MPH Gladys and Roland Harriman Professor of Medicine
by luanne-stotts
Chief, Division of Infectious Diseases. Weill Med...
Antiretroviral Updates:
Antiretroviral Updates:
by tatyana-admore
New Treatments for HIV. C. Ryan Tomlin, . Pharm.D...
Advances and Challenges in HIV Antiretroviral Therapy
Advances and Challenges in HIV Antiretroviral Therapy
by stefany-barnette
Camille Angle, Meagan Bardan, Hanna Schimjawicz a...
HIV Pharmacotherapy Focused Update
HIV Pharmacotherapy Focused Update
by yoshiko-marsland
Drew Lambert, . PharmD. lambertd@husson.edu. Huss...
Phase 2 of new ARVs Fostemsavir
Phase 2 of new ARVs Fostemsavir
by conchita-marotz
, . prodrug. of . temsavir. . (attachment inhib...
Joel E. Gallant, MD, MPH
Joel E. Gallant, MD, MPH
by mastervisa
Medical Director, Specialty . Services. Southwest ...
Switch to LPV/ r  + 3TC OLE
Switch to LPV/ r + 3TC OLE
by susan2
Study. LPV/. r. bid + 3TC or FTC . qd. + NRTI. N ...
Meg  Doherty MD MPH PhD 23 July 2018
Meg Doherty MD MPH PhD 23 July 2018
by jordyn
WHO HQ. The role of DTG based regimens in first- a...
What’s new in the 2019 WHO Guidelines:
What’s new in the 2019 WHO Guidelines:
by elina
Dolutegravir based regimens in first- ad second-li...
Switching Antiretroviral Therapy (ART) in Your African American Patients: When and How
Switching Antiretroviral Therapy (ART) in Your African American Patients: When and How
by taylor
Supported by an educational grant from Gilead Scie...
Dolutegravir   vs.  Raltegravir
Dolutegravir vs. Raltegravir
by zoe
SPRING-2 Study. Dolutegravir. versus Raltegravir....
NRTI-sparing SPARTAN PROGRESS
NRTI-sparing SPARTAN PROGRESS
by shepard237
RADAR. NEAT001/ANRS 14. 3 . A4001078. VEMAN. MODER...
Switch PI/R to ETR Etraswitch
Switch PI/R to ETR Etraswitch
by dustin869
Etraswitch. . Study. : Switch PI/r to ETR. Contin...